• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Zerion Pharma

Less than 1K followers
All
Research
Webcasts
ShowingAll content types

Zerion Pharma: A disruptive solution for poor drug solubility
Analyst Comment3/16/2023, 4:26 PM

Zerion Pharma: A disruptive solution for poor drug solubility

Zerion Pharma's CEO Ole Wiborg dived into the potential in the pipeline and the private placement.

Zerion Pharma
Zerion Pharma – A disruptive solution for poor drug solubility
Webcast3/15/2023, 12:00 PM

Zerion Pharma – A disruptive solution for poor drug solubility

Zerion Pharma
Presentation of Zerion Pharma by CEO Ole Viborg and CFO Jakob Dynes Hansen
Analyst Comment2/21/2023, 8:08 PM

Presentation of Zerion Pharma by CEO Ole Viborg and CFO Jakob Dynes Hansen

Zerion Pharma is a non-listed Danish company seeking €2-3m in a private placement round. Management will briefly run through the investment proposal and business case. Then management will focus on the regulatory environment governing the Dispersome™ technology, formulation of new drugs, and reformulation of existing drugs. Last but not least CEO Ole Wiborg will give a little flavor on the company’s strategic partnerships.

Zerion Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Zerion Pharma – Regulatory environment and strategic partnerships
Video2/20/2023, 1:30 PM

Zerion Pharma – Regulatory environment and strategic partnerships

Meet Zerion Pharma’s management and regulatory team – CEO Ole Wiborg, CFO Jakob Dynnes Hansen, and Mónica González VP Regulatory Affairs. Management will briefly run through the investment proposal and business case. Then management will focus on the regulatory environment governing the Dispersome™ technology, formulation of new drugs, and reformulation of existing drugs. Last but not least CEO Ole Wiborg will give a little flavor on the company’s strategic partnerships.

Zerion Pharma
Zerion Pharma – Company Introduction
Video2/8/2023, 10:00 AM

Zerion Pharma – Company Introduction

Zerion Pharma
Zerion Pharma - Introduction to the company
Analyst Comment2/2/2023, 4:52 PM

Zerion Pharma - Introduction to the company

Listen to Zerion Pharma’s management team – CEO Ole Wiborg and CFO Jakob Dynnes Hansen introducing the company in relation to a private placement of 2-3 mio. EUR. Zerion Pharma is a non-listed Danish company.

Zerion Pharma